Novartis acknowledged seven instances of tumors being found in children who were treated with Zolgensma for spinal muscular ...
For AI to achieve its full potential in women’s health, medical records need to tell the complete story,” experts write.
People with cognitively unimpaired Alzheimer’s “may be asymptomatic, but they do have a disease experience,” writes Jason ...
Few Americans are familiar with kratom, despite public health messaging and rising use. So what is it, and who's using it?
Novartis has acknowledged seven previously unknown instances in which tumors were found in children who were treated with its ...
Voters in 2026 midterm elections decided state health policy ballot measures on abortion rights, marijuana laws, science ...
Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US ...
Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.
PhRMA spent an estimated $59 million on search advertising over a recent seven-year period to influence how Americans view ...
Three years ago, a trial for a sickle cell gene-editing therapy a decade in the making ended abruptly after the first patient ...
Democratic doctors won big, MAHA faces an uncertain future, and what the election could mean for Medicare for All.
Medicare pushed forward a controversial plan to ban hospitals from using third parties to deliver remote patient monitoring services, despite overwhelming opposition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results